Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Cash from Financing Activities (2016 - 2025)

GeoVax Labs' Cash from Financing Activities history spans 16 years, with the latest figure at $3.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $3.0 million for Q4 2025, down 34.91% from a year ago — trailing twelve months through Dec 2025 was $19.1 million (down 19.66% YoY), and the annual figure for FY2025 was $19.1 million, down 19.66%.
  • Cash from Financing Activities for Q4 2025 was $3.0 million at GeoVax Labs, down from $8.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.5 million in Q2 2022 to a low of -$25801.0 in Q2 2021.
  • The 5-year median for Cash from Financing Activities is $6.1 million (2022), against an average of $6.8 million.
  • The sharpest move saw Cash from Financing Activities crashed 102.44% in 2021, then soared 71796.88% in 2022.
  • Year by year, Cash from Financing Activities stood at $230000.0 in 2021, then skyrocketed by 3215.45% to $7.6 million in 2022, then plummeted by 46.73% to $4.1 million in 2023, then increased by 14.91% to $4.7 million in 2024, then plummeted by 34.91% to $3.0 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $3.0 million, $8.1 million, and $209.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.